• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Hester Biosciences Limited — Updates, 11-03-2026: General Updates

    11-03-2026 | 11:16 am

    Hester Biosciences' board approved divesting 43.81% stake in subsidiary Texas Lifesciences (TLPL) for ₹9.2 Cr. TLPL, with FY25 turnover of ₹28.59 Cr and net worth of ₹13.42 Cr, will cease to be a subsidiary. Hester retains 11% stake.

    No comments yet. Be the first to comment!

    All announcements from Hester Biosciences Limited